HORMAD1 and lung adenocarcinoma: For example, tissue-specific expression of putative HR pathway regulators targeted by HORMAD1 might explain why HORMAD1 stimulates HR in lung adenocarcinomas and basal breast cancer cells and but inhibits HR in TNBC.